Andrew Chadeayne

Andrew Chadeayne's work experience includes:

- Founder and Chief Executive Officer of CaaMTech since January 2019. Andrew is leading efforts to map the chemical and patent landscapes of the psychedelics industry, with over seventy patents filed as of November 2019.

- Chief Innovations Officer at Ebbu from November 2017 to December 2018. Andrew developed a worldwide patent portfolio for cannabis formulations and related products, with the company's assets later acquired by Canopy Growth Corporation for over $400 million.

- President and Registered Patent Agent at Chadeayne, LLC from February 2011 to May 2018.

- President of SwimSpray, LLC from May 2010 to May 2017. Andrew invented, developed, patented, and commercialized a chlorine removal personal care product.

- Director of Intellectual Property at NewMarket Pharmaceuticals from November 2011 to November 2013. Andrew worked with R&D and inventors to identify patentable subject matter, drafted patent applications, and managed the intellectual property portfolio.

- Patent Agent at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP from August 2006 to February 2011.

Andrew Chadeayne obtained their Bachelor of Arts degree in Neuropsychology and Chemistry from Princeton University in the years 1997 to 2001. Andrew then pursued further education and completed their Doctor of Philosophy (PhD) in Chemistry at Cornell University from 2001 to 2006. Following their PhD, Andrew attended The George Washington University Law School, where they obtained their J.D. degree in Patent Law from 2007 to 2011. Additionally, they obtained the United States Patent and Trademark Office Registration certification from USPTO in 2007. Before their higher education, Andrew attended Pleasantville High School, although specific dates and degrees are not provided.